Open Medicine

Papers
(The H4-Index of Open Medicine is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
The relationship between IFN-γ, IL-10, IL-6 cytokines, and severity of the condition with serum zinc and Fe in children infected with Mycoplasma pneumoniae108
Trends and future directions of autophagy in osteosarcoma: A bibliometric analysis95
Identification and validation of autophagy-related genes in SSc68
Knockdown of CCNB1 alleviates high glucose-triggered trophoblast dysfunction during gestational diabetes via Wnt/β-catenin signaling pathway47
The application of intravenous general anesthesia under nasopharyngeal airway assisted ventilation undergoing ureteroscopic holmium laser lithotripsy: A prospective, single-center, controlled trial42
Temporal muscle thickness is not a prognostic predictor in patients with high-grade glioma, an experience at two centers in China37
Construction of a ceRNA network to reveal a vascular invasion associated prognostic model in hepatocellular carcinoma33
Menstrual irregularities associated with COVID-19 vaccines among women in Saudi Arabia: A survey during 202224
Evaluation of quality of life in patients with schizophrenia: An inpatient social welfare institution-based cross-sectional study23
Vitamin C and epigenetics: A short physiological overview23
β2-Adrenergic receptor expression in subchondral bone of patients with varus knee osteoarthritis22
Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis18
Retraction of “SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis”16
Cimifugin inhibits adipogenesis and TNF-α-induced insulin resistance in 3T3-L1 cells16
Mechanism research on inhibition of gastric cancer in vitro by the extract of Pinellia ternata based on network pharmacology and cellular metabolomics15
Antiangiogenic potential of Elaeagnus umbellata extracts and molecular docking study by targeting VEGFR-2 pathway15
0.15744805335999